Semaglutide or Tirzepatide cannot be prescribed to anyone with the following and should not be purchased: BMI under 27, eating disorder, gallbladder disease, drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer, currently pregnant or breastfeeding, planning to become pregnant, Diabetic retinopathy, Multiple endocrine neoplasia type 2, family history of medullary thyroid carcinoma thyroid carcinoma
This can lead to fewer blood sugar spikes and a reduced need for additional medications
Understanding Weight Loss Surgery Safety Like any major surgery, bariatric procedures involve certain risks that should be carefully considered
Generative AI statement The author(s) declared that Generative AI was used in the creation of this manuscript
In qualitative interviews with Retatrutide trial participants, 31 of 36 treated individuals reported changes in eating behaviors within the trials first eight weeks